Tenth Annual Boston Angiogenesis Meeting
Tenth Annual Boston Angiogenesis Meeting
Friday, November 7, 2008
Friday, November 7th, 2008
Starr Center, Schepens Eye Research Institute
Patricia A. D'Amore, Ph.D., Organizer
Keynote Speaker:
Marsha A. Moses, Ph.D.
Professor of Surgery, Harvard Medical School,
Children's Hospital Boston
Please click here to register on-line...
Agenda
Opening Remarks: Patricia D’Amore, Ph.D., Schepens Eye Research Institute
Keynote Speaker: Marsha Moses, Ph.D., Children’s Hospital
“Molecular regulation of angiogenesis: From the angiogenic switch
through tumor progress, implications for therapy, diagnosis and
prognosis”
Moderators
-
Harold F. Dvorak, M.D., Beth Israel Deaconess Medical Center
-
Ira Herman, Ph.D., Tufts University School of Medicine
-
Stella Kourembanas, M.D., Children's Hospital
Speakers
-
Zoltan Arany, M.D., Beth Israel Deaconess Medical Center
“Regulation of angiogenesis by the PGC-1 coactivators” -
Silvia Corvera, M.D., University of Massachusetts Medical Center
“Human adipose tissue angiogenesis in metabolic disease” -
Dai Fukumura, M.D., Ph.D., Massachusetts General Hospital
“Perivascular nitric oxide gradients normalize tumor vasculature” -
Chenguha Gu, Ph.D., D.V.M., Harvard Medical School
“The molecular mechanisms of axon and vascular guidance” -
Ali Hafezi-Moghadam, M.D., Ph.D., Massachusetts Eye & Ear Infirmary
“Non-invasive molecular imaging, lessons from invading leukocytes” -
Martin Hemler, Ph.D., Dana Farber Cancer Institute
“Tetraspanin CD151 contributes at multiple levels to tumor progression” -
Hyung Keun Lee, M.D., Ph.D., Schepens Eye Research Institute
“A novel tyrosine kinase-based pathway for regulation of hemangiogenesis” -
Dipak Panigrahy, M.D., Children’s Hospital
“Targeting the tumor stroma through PPARs” -
Joseph Vacanti, M.D., Massachusetts General Hospital
“Tissue engineering: Its roots in angiogenesis” -
Jiang Yang, Ph.D., Children’s Hospital
“Neutrophil gelatinase-associated lipocalin promotes breast cancer progression: Mechanistic studies and clinical implications”


